ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

INAB IN8bio Inc

1.12
-0.56 (-33.33%)
2024年6月15日 - 終了
15分遅延
名称 銘柄コード 市場 種別
IN8bio Inc INAB NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.56 -33.33% 1.12 13:00:11
始値 安値 高値 終値 前日終値
1.50 1.06 1.50 1.09 1.68
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/1506:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1506:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1506:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1506:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1405:07EDGAR2Form 8-K - Current report
2024/6/1405:01GLOBEIN8bio Presents Positive Data Demonstrating Durable 1-year..
2024/6/0321:53EDGAR2Form 8-K - Current report
2024/6/0319:05GLOBEIN8bio Presents Progression-Free Survival Update from Phase..
2024/5/2421:00GLOBEIN8bio to Present at International Society for Cell & Gene..
2024/5/2406:00GLOBEIN8bio Announces INB-200 Phase 1 Study Data in Newly..
2024/5/1423:00GLOBEIN8bio Announces Upcoming Presentation at 2024 European..
2024/5/1321:00GLOBEIN8bio Demonstrates Robust and Reproducible Gamma-Delta T..
2024/5/1005:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1005:04EDGAR2Form 8-K - Current report
2024/5/1005:00GLOBEIN8bio Reports First Quarter 2024 Financial Results and..
2024/5/0805:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/4/3019:05GLOBEIN8bio Doses First Patient in Phase 2 Clinical Trial of..
2024/4/2421:00GLOBEIN8bio Announces Oral Presentation at the Upcoming American..
2024/4/1705:05GLOBEIN8bio to Present at Noble Capital Markets Emerging Growth..
2024/4/1005:30GLOBEIN8bio Announces New Preclinical Data for Gamma-Delta..
2024/3/1505:00GLOBEIN8bio Reports Fourth Quarter and Full-Year 2023 Financial..
2024/3/0606:30GLOBEIN8bio to Present New Preclinical Data on Novel Gamma-Delta..
2024/2/2622:00BWIN8bio to Present at Upcoming Investor Conferences
2024/2/1422:00GLOBEIN8bio Announces Publication on Novel Gamma-Delta T Cell..
2024/2/0906:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0906:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0906:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0906:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0906:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0906:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2006:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/1/1914:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/1/1906:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/1/1307:16EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/1/0422:00GLOBEIN8bio Highlights Recent Company Accomplishments and..
2023/12/1606:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2023/12/1522:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1522:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1522:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1522:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1522:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1522:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1522:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1520:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/12/1420:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1207:15EDGAR2Form 8-K - Current report
2023/12/1206:05GLOBEIN8bio Announces Positive Clinical Update Demonstrating..
2023/12/1123:00GLOBEIN8bio Announces Pricing of Financing Totaling up to $46.9..
2023/12/1122:56EDGAR2Form 8-K - Current report
2023/12/0906:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock